Evidence map›Paper›PMID 40822011›Full record

ArticleFrontiers in cardiovascular medicine2025

Evaluation of FFR and CPET in patients with

Lingli Guo, Hengdao Liu, Xi Zhao, Ting Liu, Chenyang Gao, Jihao Duan, Dongfeng Wang, Junwei Zhao, Yuzhen Wei, Ruipeng Song and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lingli Guo *Gastroscopy Center, The Third People's Hospital of Henan Province, Zhengzhou, Henan, China.
Hengdao Liu *Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xi Zhao *Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Ting Liu *Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Chenyang GaoDepartment of Cardiology, Neihuang People's Hospital, Anyang, Henan, China.
Jihao DuanDepartment of Cardiology, Luohe Third People's Hospital, Luohe, Henan, China.
Dongfeng WangDepartment of Cardiology, Luohe Third People's Hospital, Luohe, Henan, China.
Junwei ZhaoDepartment of Cardiology, Yexian People's Hospital, Pingdingshan, Henan, China.
Yuzhen WeiDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Ruipeng SongGastroscopy Center, The Third People's Hospital of Henan Province, Zhengzhou, Henan, China.
Hailong TaoDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Drug-coated balloon (DCB) is a novel therapeutic strategy for Methods and results: In this retrospective study, 100 patients were enrolled and classified into the DCB group ( Conclusions: DCB treatment for

Indexed as

cardiopulmonary exercise testingcoronary chronic total occlusiondrug-coated balloondrug-eluting stentfractional flow reserve

Identifiers

PMID40822011
PMCPMC12350347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.